Article
Infectious Diseases
Romain Palich, Clotilde Allavena, Gilles Peytavin, Cathia Soulie, Roland Tubiana, Laurence Weiss, Ana Montoya Ferrer, Claudine Duvivier, Olivier Bouchaud, Julie Bottero, Aurore Durand, Minh-Patrick Le, Anne-Genevieve Marcelin, Yasmine Dudoit, Lambert Assoumou, Christine Katlama
Summary: The study aimed to evaluate the efficacy of switching patients from a twice-daily to a once-daily regimen of etravirine/raltegravir in maintaining viral suppression. The results showed a low rate of virological failure and a high treatment success rate at 48 weeks post-switch.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2021)
Article
Rheumatology
Chhavi Asthana, Gregory M. Peterson, Madhur D. Shastri, Rahul P. Patel
Summary: The study aimed to compare the pharmacokinetics of Rotta- and non-Rotta-manufactured glucosamine products in healthy volunteers, revealing significant interindividual differences in absorption and elimination; the results showed no significant differences in pharmacokinetic parameters between the two brands, but considerable variability among participants, which may impact clinical outcomes.
Article
Clinical Neurology
Maria Faurholt-Jepsen, Jonas Busk, Maj Vinberg, Ellen Margrethe Christensen, Helgathorarinsdottir, Mads Frost, Jakob E. Bardram, Lars Vedel Kessing
Summary: The study found differences in location data between patients with bipolar disorder and healthy control individuals, as well as variations in location data between different affective states within bipolar disorder. Utilizing smartphone-based location data may be a promising measure to monitor illness and illness activity in patients with bipolar disorder.
JOURNAL OF AFFECTIVE DISORDERS
(2021)
Article
Microbiology
Veenu Bala, Yashpal S. Chhonker, Abdullah Alshehri, Constant Edi, Catherine M. Bjerum, Benjamin G. Koudou, Christopher L. King, Daryl J. Murry
Summary: The study developed a population pharmacokinetics (PK) model for DEC and identified body weight and gender as significant covariates for DEC volume of distribution (V/F), which provided a comprehensive description of the pharmacokinetics of DEC in the studied population.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2021)
Article
Multidisciplinary Sciences
Kanitha Tiankanon, Stephen J. Kerr, Siriwan Thongthip, Suwasin Udomkarnjananun, Pimpayao Sodsai, Athaya Vorasittha, Kamol Panumatrassamee, Kullaya Takkavatakarn, Kriang Tungsanga, Somchai Eiam-Ong, Kearkiat Praditpornsilpa, Yingyos Avihingsanon, Natavudh Townamchai
Summary: Converting from BID TAC to OD TAC provided similar AUC(0-24) regardless of CYP3A5 genotypic polymorphism, but the C-trough was lower in the CYP3A5 expressor group.
SCIENTIFIC REPORTS
(2022)
Article
Respiratory System
Weimin Li, Sami Z. Daoud, Roopa Trivedi, Pradeep B. Lukka, Eulalia Jimenez, Eduard Molins, Catherine Stewart, Pranob Bharali, Esther Garcia-Gil
Summary: This study aimed to investigate the pharmacokinetics and safety profile of Aclidinium in healthy Chinese participants. The results showed that single and multiple doses of Aclidinium were well tolerated in the Chinese population, with pharmacokinetic characteristics similar to Caucasian populations.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
(2023)
Article
Infectious Diseases
Bela Shah, Deval Mistry, Dharmender Jairam, Kajal Kansara, Rutvi Pandya, Presha Vasani, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Hanmant Barkate
Summary: This study aimed to compare the efficacy of two antifungal drugs, SB-50mg and SB-65mg, in the treatment of dermatophytosis. The results showed that the complete cure rate and symptom resolution rate were significantly higher in the SB-65mg group than in the SB-50mg group after 6 weeks of treatment. Similar results were obtained in a subgroup analysis of recalcitrant dermatophytosis. This suggests that SB-65mg has a higher efficacy in the management of dermatophytosis.
INFECTION AND DRUG RESISTANCE
(2023)
Article
Oncology
Francois Guilhot, Francoise Rigal-Huguet, Joelle Guilhot, Agnes-Paule Guerci-Bresler, Frederic Maloisel, Delphine Rea, Valerie Coiteux, Martine Gardembas, Christian Berthou, Anne Vekhoff, Eric Jourdan, Marc Berger, Loic Fouillard, Magda Alexis, Laurence Legros, Philippe Rousselot, Alain Delmer, Pascal Lenain, Martine Escoffre Barbe, Emmanuel Gyan, Claude-Eric Bulabois, Viviane Dubruille, Bertrand Joly, Bertrand Pollet, Pascale Cony-Makhoul, Hyacinthe Johnson-Ansah, Melanie Mercier, Denis Caillot, Aude Charbonnier, Jean-Jacques Kiladjian, Jacques Chapiro, Amelie Penot, Veronique Dorvaux, Iona Vaida, Alberto Santagostino, Lydia Roy, Hacene Zerazhi, Eric Deconinck, Herve Maisonneuve, Isabelle Plantier, Delphine Lebon, Yazid Arkam, Nathalie Cambier, Kamel Ghomari, Jean-Michel Miclea, Sylvie Glaisner, Jean-Michel Cayuela, Jean-Claude Chomel, Marc Muller, Ludovic Lhermitte, Marc Delord, Claude Preudhomme, Gabriel Etienne, Francois-Xavier Mahon, Franck- Emmanuel Nicolini
Summary: The STI571 prospective randomised trial (SPIRIT) French trial compared different treatment options for chronic-phase chronic myeloid leukaemia (CML) and found similar overall and progression-free survival rates across all treatment arms at 15 years. The combination of imatinib (IM) 400 mg + pegylated interferon alpha2a (PegIFN-alpha 2a) had significantly higher rates of major molecular response at 12 months and deep molecular response (MR4) over time compared to IM 400 mg alone.
Article
Microbiology
Sonya Tang Girdwood, Min Dong, Peter Tang, Erin Stoneman, Rhonda Jones, Toni Yunger, Austin Ostermeier, Calise Curry, Melissa Forton, Traci Hail, Randi Mullaney, Patrick Lahni, Nieko Punt, Jennifer Kaplan, Alexander A. Vinks
Summary: This study developed population PK models of ceftriaxone in children admitted to a pediatric intensive care unit (PICU) and evaluated different dosing regimens. The study found that patient weight, age, creatinine clearance, and temperature significantly affected ceftriaxone clearance, while the presence of sepsis and phase of illness did not have a significant effect on PK parameters.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2022)
Article
Pharmacology & Pharmacy
Vera E. Bukkems, Teun M. Post, Angela P. Colbers, David M. Burger, Elin M. Svensson
Summary: A population pharmacokinetic model was developed to predict the pharmacokinetic profile of raltegravir 1200 mg once daily in pregnant women. The study found that the efficacy target was not met, indicating that the current recommendation is to avoid using the 1200 mg once-daily raltegravir regimen during pregnancy.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
(2021)
Article
Multidisciplinary Sciences
Francis Appiah-Twum, Jewelna Akorli, Lydia Okyere, Kate Sagoe, Dickson Osabutey, Michael Cappello, Michael D. Wilson
Summary: Microbes have an important role in human gut health and treatment outcomes. A study in Ghana found low cure rates for hookworm infection after albendazole treatment, and identified associations between the gut microbiome and treatment outcomes. Hookworm infection was associated with increased species richness, and individuals who were cured of the infection showed a significant reduction in microbiota composition. The study suggests a relationship between gut microbiome dysbiosis and albendazole therapy outcomes, and future research will focus on identifying specific biomarkers and exploring probiotic supplementation as an adjunct treatment.
SCIENTIFIC REPORTS
(2023)
Article
Infectious Diseases
Maria Goretti Lopez-Ramos, Joan Vinent, Rob Aarnoutse, Angela Colbers, Eneritz Velasco-Arnaiz, Loreto Martorell, Lola Falcon-Neyra, Olaf Neth, Luis Prieto, Sara Guillen, Fernando Baquero-Artigao, Ana Mendez-Echevarria, David Gomez-Pastrana, Ana Belen Jimenez, Rebeca Lahoz, Jose Tomas Ramos-Amador, Antoni Soriano-Arandes, Begona Santiago, Rosa Farre, Claudia Fortuny, Dolors Soy, Antoni Noguera-Julian
Summary: In 2010, the WHO recommended increasing the daily doses of first-line anti-tuberculosis medicines in children. This study aimed to investigate the pharmacokinetics of a once-daily dose of isoniazid (INH) in infants under 6 months of age. The study found that the target adult levels were not reached in a few cases, but overall, the treatment was well tolerated and no major safety concerns were raised.
Article
Veterinary Sciences
Mizuki Kita, Kazutaka Kanai, Hiroki Mitsuhashi, Tomoki Noguchi, Noriaki Nagai, Mizuki Yamaguchi, Yuya Otaka, Rina Kudo, Yohei Yamashita, Kazuki Tajima
Summary: The study demonstrated that magnesium hydroxide nanoparticles (nMH) can improve the ocular hypotensive effect of timolol maleate (TM) without enhancing its side effects. The fixed combination of nMH-TM may be more effective for lowering intraocular pressure in dogs compared to TM alone.
VETERINARY SCIENCES
(2021)
Article
Pharmacology & Pharmacy
Ryohei Ono, Kenichi Fukushima, Tatsuro Yamazaki, Daichi Yamashita, Hidehisa Takahashi, Yasuhiko Hori, Kazutaka Nishimura
Summary: This study found significant differences in anti-factor Xa activity and coagulation markers between VTE patients receiving 10 mg apixaban compared to those receiving 5 mg. Patients meeting NVAF DAC criteria had significantly higher anti-factor Xa activity and prothrombin time values compared to those not meeting the criteria. The findings suggest individualized dose adjustments may be necessary when using higher doses of apixaban in VTE patients.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
(2022)
Article
Oncology
Yi-Han Chien, Gudrun Wuerthwein, Pablo Zubiaur, Bianca Posocco, Maria Angeles Pena, Alberto M. Borobia, Sara Gagno, Francisco Abad-Santos, Georg Hempel
Summary: This study investigated the pharmacokinetics of Imatinib in patients under long-term treatment and compared the differences in pharmacokinetics between healthy volunteers and patients.
CANCER CHEMOTHERAPY AND PHARMACOLOGY
(2022)
Article
Chemistry, Analytical
Li Sun, Hankun Li, Kenneth Willson, Sheila Breidinger, Matthew L. Rizk, Larissa Wenning, Eric J. Woolf
ANALYTICAL CHEMISTRY
(2012)
Article
Microbiology
Marian Iwamoto, Larissa A. Wenning, Amelia S. Petry, Martine Laethem, Marina De Smet, James T. Kost, Sheila A. Breidinger, Eric C. Mangin, Neal Azrolan, Howard E. Greenberg, Wouter Haazen, Julie A. Stone, Keith M. Gottesdiener, John A. Wagner
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2008)
Article
Microbiology
Marian Iwamoto, William D. Hanley, Amelia S. Petry, Evan J. Friedman, James T. Kost, Sheila A. Breidinger, Kenneth C. Lasseter, Richard Robson, Norman M. Lunde, Larissa A. Wenning, Julie A. Stone, John A. Wagner
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2009)
Article
Microbiology
David Croteau, Scott Letendre, Brookie M. Best, Ronald J. Ellis, Sheila Breidinger, David Clifford, Ann Collier, Benjamin Gelman, Christina Marra, Gilbert Mbeo, Allen McCutchan, Susan Morgello, David Simpson, Lauren Way, Florin Vaida, Susan Ueland, Edmund Capparelli, Igor Grant
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2010)
Article
Oncology
Mark Stroh, John Palcza, Jacqueline McCrea, Sabrina Marsilio, Sheila Breidinger, Deborah Panebianco, Amy Johnson-Levonas, Walter K. Kraft, Keith Orford, Gail Murphy, Nancy Agrawal, Michele Trucksis, John A. Wagner, Marian Iwamoto
CANCER CHEMOTHERAPY AND PHARMACOLOGY
(2012)
Editorial Material
Immunology
Marian Iwamoto, Larissa A. Wenning, Goutam C. Mistry, Amelia S. Petry, Sarah Y. Liou, Kaylan Ghosh, Sheila Breidinger, Neal Azrolan, Maria J. Gutierrez, William E. Bridson, Julie A. Stone, Keith M. Gottesdiener, John A. Wagner
CLINICAL INFECTIOUS DISEASES
(2008)
Article
Immunology
Marian Iwamoto, Larissa A. Wenning, Bach-Yen Nguyen, Hedy Teppler, Allison R. Moreau, Rand R. Rhodes, William D. Hanley, Bo Jin, Charlotte M. Harvey, Sheila A. Breidinger, Neal Azrolan, H. Frank Farmer, Robin D. Isaacs, Jeffery A. Chodakewitz, Julie A. Stone, John A. Wagner
CLINICAL INFECTIOUS DISEASES
(2009)
Article
Pharmacology & Pharmacy
L. A. Wenning, A. S. Petry, J. T. Kost, B. Jin, S. A. Breidinger, I. DeLepeleire, E. J. Carlini, S. Young, T. Rushmore, F. Wagner, N. M. Lunde, F. Bieberdorf, H. Greenberg, J. A. Stone, J. A. Wagner, M. Iwamoto
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2009)
Article
Biochemical Research Methods
M. D. G. Anderson, S. A. Breidinger, E. J. Woolf
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
(2009)
Article
Biochemical Research Methods
Li Sun, Sabrina Forni, Michael S. Schwartz, Sheila Breidinger, Eric J. Woolf
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
(2012)
Article
Pharmacology & Pharmacy
M. Iwamoto, J. T. Kost, G. C. Mistry, L. A. Wenning, S. A. Breidinger, T. C. Marbury, J. A. Stone, K. M. Gottesdiener, D. M. Bloomfield, J. A. Wagner
JOURNAL OF CLINICAL PHARMACOLOGY
(2008)
Article
Pharmacology & Pharmacy
Diana M. Brainard, Evan J. Friedman, Bo Jin, Sheila A. Breidinger, Maria D. Tillan, Larissa A. Wenning, Julie A. Stone, Jeffrey A. Chodakewitz, John A. Wagner, Marian Iwamoto
JOURNAL OF CLINICAL PHARMACOLOGY
(2011)
Article
Pharmacology & Pharmacy
Mark Stroh, Jennifer Talaty, Punam Sandhu, Jacqueline McCrea, Amita Patnaik, Anthony Tolcher, John Palcza, Keith Orford, Sheila Breidinger, Narayana Narasimhan, Deborah Panebianco, Richard Lush, Kyriakos P. Papadopoulos, John A. Wagner, Michele Trucksis, Nancy Agrawal
JOURNAL OF CLINICAL PHARMACOLOGY
(2014)
Article
Pharmacology & Pharmacy
M. Iwamoto, L. A. Wenning, A. S. Petry, M. Laethem, M. De Smet, J. T. Kost, S. A. Merschman, K. M. Strohmaier, S. Ramael, K. C. Lasseter, J. A. Stone, K. M. Gottesdiener, J. A. Wagner
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2008)